Docebo Inc. Announces Voting Results from its Annual General Meeting of Shareholders
TORONTO--(BUSINESS WIRE)--Jun 10, 2025--
Docebo Inc. (NASDAQ: DCBO; TSX: DCBO) (' Docebo ' or the ' Company ') announced today the results of voting at its annual general meeting of shareholders held on June 10, 2025 (the ' Meeting ').
Each of the seven nominees listed in the Company's management information circular dated April 7, 2025 provided in connection with the Meeting were elected as directors of the Company. Docebo received proxies and virtual votes at the Meeting as set out below:
In addition, Docebo reports that an ordinary resolution approving the appointment of KPMG LLP as Docebo's auditors for the 2025 fiscal year was passed by a majority of the votes represented at the Meeting.
Details of the voting results on all matters considered at the Meeting are available in the Company's report of voting results, which is available under Docebo's profile on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov.
About Docebo
Docebo is redefining the way enterprises leverage technology to create and manage content, deliver training, and measure the business impact of their learning programs. With Docebo's end-to-end learning platform, organizations worldwide are equipped to deliver scaled, personalized learning across all their audiences and use cases, driving growth and powering their business.
View source version on businesswire.com:https://www.businesswire.com/news/home/20250610618993/en/
CONTACT: For further information, please contact:Mike McCarthy
Vice President – Investor Relations
(214) 830-0641
[email protected]
KEYWORD: NORTH AMERICA CANADA
INDUSTRY KEYWORD: TECHNOLOGY HUMAN RESOURCES SECURITY PROFESSIONAL SERVICES SOFTWARE OTHER EDUCATION CONTINUING TRAINING EDUCATION ARTIFICIAL INTELLIGENCE
SOURCE: Docebo Inc.
Copyright Business Wire 2025.
PUB: 06/10/2025 11:48 AM/DISC: 06/10/2025 11:47 AM
http://www.businesswire.com/news/home/20250610618993/en
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
40 minutes ago
- Yahoo
Fred Smith, FedEx founder and parcel industry pioneer, dies at 80
Frederick W. Smith, who founded FedEx Express Corp. fifty-four years ago and revolutionized the parcel delivery business by using aircraft for overnight delivery, died Saturday, the company said on its website. He was 80. 'Fred was more than just the pioneer of an industry and the founder of our great company. He was the heart and soul of FedEx – its People-Service-Profit culture, values, integrity, and spirit. He was a mentor to many and a source of inspiration to all. He was also a proud father, grandfather, husband, Marine, and friend. Please keep the entire Smith family in your thoughts and prayers during this difficult time,' said CEO Raj Subramaniam in a message to FedEx employees. FedEx has grown into an $87.7 billion enterprise with the largest air cargo fleet in the world. It not only transformed the express parcel industry, but became instrumental to the U.S. economy and international trade by transporting documents and packages. Today, it moves more than $2 trillion worth of goods annually, relying on more than 700 aircraft serving 650 airports around the world, 220,000 vehicles and about 5,000 operating facilities. It also operates an extensive U.S. ground network, the largest less-than-truckload carrier in the United States and a major supply chain division. 'Fred Smith is still a legend. In his lifetime he built a company that is as big as UPS, which had a 70-year head start,' said Satish Jindel, a parcel industry expert and president of ShipMatrix who years ago helped FedEx acquire RPS and turn it into FedEx Ground. Fred Smith was born in Marks, Mississippi, in 1944. As a Yale undergraduate, Fred Smith wrote a term paper outlining a system to accommodate urgent, time-sensitive shipments such as medicine, computer parts, and electronics. He received an average grade. After four years of service in the Marines, including two tours of duty in Vietnam where he received the Silver Star, Bronze Star and two Purple Hearts, he purchased in 1970 the controlling interest in a Little Rock, Arkansas-based aircraft maintenance company, Ark Aviation Sales, run by his stepfather and turned its focus to trading used jets. The next year, he established the FedEx Express Corp. with his $4 million inheritance and $91 million in venture capital. Two years later he relocated to Memphis, Tennessee, because of its central location and lack of severe weather conditions, which helped maintain schedule reliability for the airline. On the first night of continuous operation, 389 Federal Express workers and 14 Dassault Falcon jets delivered 186 packages overnight to 25 U.S. cities – giving birth to the modern express industry. Smith developed FedEx as a freight version of a bank clearing house where one bank clearing house was located in the middle of affiliate banks and all representatives were sent to the central location to exchange materials, according to one of his biographies. Smith had to go to great lengths to keep the company afloat in the early days. In one instance, after a crucial business loan was denied, he took the company's last $5,000 to Las Vegas and won $27,000 gambling on blackjack to cover the company's $24,000 fuel bill. It kept FedEx alive for one more week, according to a biography. In 1977, FedEx purchased seven Boeing 727 aircraft, each with a cargo capacity of 40,000 pounds – almost seven times that of the Dassault Falcon. The company was publicly listed on the New York Stock Exchange in 1978 and in 1981 it moved into its global air sortation hub at Memphis International Airport. Ten years after its launch, FedEx achieved $1 billion in revenue. In 1984, FedEx acquired Gelco Express International, a worldwide courier with service to 84 countries. It also launched operations in the Asia Pacific and regular scheduled flights to Europe. The following year it opened its European headquarters in Brussels, Belgium. In 1989, FedEx purchased cargo airline Flying Tigers. FedEx acquired TNT Express, a major European parcel carrier, in 2016. In 2000, Smith made an appearance as himself in the Tom Hanks movie 'Cast Away,' which was filmed on location at FedEx's home in Memphis. Smith was a fierce advocate for free trade in Washington, where friends included President George W. Bush and Sen. John McCain. Bush offered Smith the job of defense secretary for his second term, but Smith declined to spend time with his terminally ill daughter. Smith met with President Donald Trump at the White House earlier this year. Smith is a member of the Aviation Hall of Fame and the Business Hall of Fame. In 2014, Fortune Magazine named him among the world's 50 greatest leaders. Click here for more FreightWaves/American Shipper stories by Eric Kulisch. Amazon taps FedEx for big-and-bulky residential deliveries Lawmaker blames FedEx pressure, Trump bungling for de minimis U-turn The post Fred Smith, FedEx founder and parcel industry pioneer, dies at 80 appeared first on FreightWaves.
Yahoo
an hour ago
- Yahoo
Mountview Estates (LON:MTVW) Is Paying Out A Dividend Of £2.75
The board of Mountview Estates P.L.C. (LON:MTVW) has announced that it will pay a dividend of £2.75 per share on the 18th of August. Based on this payment, the dividend yield on the company's stock will be 5.4%, which is an attractive boost to shareholder returns. We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. While it is great to have a strong dividend yield, we should also consider whether the payment is sustainable. At the time of the last dividend payment, Mountview Estates was paying out a very large proportion of what it was earning and 1,081% of cash flows. This is certainly a risk factor, as reduced cash flows could force the company to pay a lower dividend. Looking forward, EPS could fall by 3.7% if the company can't turn things around from the last few years. If the dividend continues along the path it has been on recently, the payout ratio in 12 months could be 96%, which is definitely a bit high to be sustainable going forward. View our latest analysis for Mountview Estates The company's dividend history has been marked by instability, with at least one cut in the last 10 years. Since 2015, the dividend has gone from £2.00 total annually to £5.25. This works out to be a compound annual growth rate (CAGR) of approximately 10% a year over that time. Mountview Estates has grown distributions at a rapid rate despite cutting the dividend at least once in the past. Companies that cut once often cut again, so we would be cautious about buying this stock solely for the dividend income. With a relatively unstable dividend, it's even more important to evaluate if earnings per share is growing, which could point to a growing dividend in the future. Over the past five years, it looks as though Mountview Estates' EPS has declined at around 3.7% a year. A modest decline in earnings isn't great, and it makes it quite unlikely that the dividend will grow in the future unless that trend can be reversed. Overall, it's nice to see a consistent dividend payment, but we think that longer term, the current level of payment might be unsustainable. The payments are bit high to be considered sustainable, and the track record isn't the best. Overall, we don't think this company has the makings of a good income stock. Companies possessing a stable dividend policy will likely enjoy greater investor interest than those suffering from a more inconsistent approach. However, there are other things to consider for investors when analysing stock performance. For example, we've identified 2 warning signs for Mountview Estates (1 is concerning!) that you should be aware of before investing. Is Mountview Estates not quite the opportunity you were looking for? Why not check out our selection of top dividend stocks. — Investing narratives with Fair Values Vita Life Sciences Set for a 12.72% Revenue Growth While Tackling Operational Challenges By Robbo – Community Contributor Fair Value Estimated: A$2.42 · 0.1% Overvalued Vossloh rides a €500 billion wave to boost growth and earnings in the next decade By Chris1 – Community Contributor Fair Value Estimated: €78.41 · 0.1% Overvalued Intuitive Surgical Will Transform Healthcare with 12% Revenue Growth By Unike – Community Contributor Fair Value Estimated: $325.55 · 0.6% Undervalued View more featured narratives — Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Se produjo un error al recuperar la información Inicia sesión para acceder a tu portafolio Se produjo un error al recuperar la información Se produjo un error al recuperar la información Se produjo un error al recuperar la información Se produjo un error al recuperar la información
Yahoo
an hour ago
- Yahoo
Are Poor Financial Prospects Dragging Down Fresenius Medical Care AG (ETR:FME Stock?
With its stock down 9.1% over the past month, it is easy to disregard Fresenius Medical Care (ETR:FME). We decided to study the company's financials to determine if the downtrend will continue as the long-term performance of a company usually dictates market outcomes. Particularly, we will be paying attention to Fresenius Medical Care's ROE today. Return on Equity or ROE is a test of how effectively a company is growing its value and managing investors' money. In short, ROE shows the profit each dollar generates with respect to its shareholder investments. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. Return on equity can be calculated by using the formula: Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity So, based on the above formula, the ROE for Fresenius Medical Care is: 5.2% = €812m ÷ €16b (Based on the trailing twelve months to March 2025). The 'return' is the amount earned after tax over the last twelve months. So, this means that for every €1 of its shareholder's investments, the company generates a profit of €0.05. Check out our latest analysis for Fresenius Medical Care We have already established that ROE serves as an efficient profit-generating gauge for a company's future earnings. Based on how much of its profits the company chooses to reinvest or "retain", we are then able to evaluate a company's future ability to generate profits. Generally speaking, other things being equal, firms with a high return on equity and profit retention, have a higher growth rate than firms that don't share these attributes. When you first look at it, Fresenius Medical Care's ROE doesn't look that attractive. However, given that the company's ROE is similar to the average industry ROE of 5.1%, we may spare it some thought. But Fresenius Medical Care saw a five year net income decline of 21% over the past five years. Bear in mind, the company does have a slightly low ROE. Hence, this goes some way in explaining the shrinking earnings. However, when we compared Fresenius Medical Care's growth with the industry we found that while the company's earnings have been shrinking, the industry has seen an earnings growth of 16% in the same period. This is quite worrisome. The basis for attaching value to a company is, to a great extent, tied to its earnings growth. It's important for an investor to know whether the market has priced in the company's expected earnings growth (or decline). By doing so, they will have an idea if the stock is headed into clear blue waters or if swampy waters await. Is Fresenius Medical Care fairly valued compared to other companies? These 3 valuation measures might help you decide. With a high three-year median payout ratio of 55% (implying that 45% of the profits are retained), most of Fresenius Medical Care's profits are being paid to shareholders, which explains the company's shrinking earnings. With only a little being reinvested into the business, earnings growth would obviously be low or non-existent. Moreover, Fresenius Medical Care has been paying dividends for at least ten years or more suggesting that management must have perceived that the shareholders prefer dividends over earnings growth. Upon studying the latest analysts' consensus data, we found that the company's future payout ratio is expected to drop to 39% over the next three years. As a result, the expected drop in Fresenius Medical Care's payout ratio explains the anticipated rise in the company's future ROE to 8.3%, over the same period. On the whole, Fresenius Medical Care's performance is quite a big let-down. Because the company is not reinvesting much into the business, and given the low ROE, it's not surprising to see the lack or absence of growth in its earnings. With that said, we studied the latest analyst forecasts and found that while the company has shrunk its earnings in the past, analysts expect its earnings to grow in the future. To know more about the company's future earnings growth forecasts take a look at this free report on analyst forecasts for the company to find out more. — Investing narratives with Fair Values Vita Life Sciences Set for a 12.72% Revenue Growth While Tackling Operational Challenges By Robbo – Community Contributor Fair Value Estimated: A$2.42 · 0.1% Overvalued Vossloh rides a €500 billion wave to boost growth and earnings in the next decade By Chris1 – Community Contributor Fair Value Estimated: €78.41 · 0.1% Overvalued Intuitive Surgical Will Transform Healthcare with 12% Revenue Growth By Unike – Community Contributor Fair Value Estimated: $325.55 · 0.6% Undervalued View more featured narratives — Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
